As the COVID-19 pandemic continues its global march, overwhelming even the most sophisticated health systems, there is an urgent need for real-time, reliable evidence to allow for rapid responses to changing and challenging operating settings.
This makes Monitoring Evaluation Research and Learning (MERL) more important than ever, and we must adapt approaches and tools to remain relevant. Coffey’s in-house Research Monitoring and Evaluation (RME) team has developed the following advice for consideration: